72
Participants
Start Date
June 30, 2014
Primary Completion Date
September 9, 2017
Study Completion Date
June 4, 2019
Ibrance
Bicalutamide
Zoladex
Lupron Depot
Thomas Jefferson University, Philadelphia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Vanderbilt-Ingram Cancer Center, Nashville
University of Michigan Hospital, Ann Arbor
Northwestern University, Chicago
Washington University in St. Louis, St Louis
Huntsman Cancer Institute, University of Utah, Salt Lake City
City of Hope Cancer Center, Duarte
University of Utah
OTHER
Vanderbilt-Ingram Cancer Center
OTHER
Johns Hopkins University
OTHER
Thomas Jefferson University
OTHER
Washington University School of Medicine
OTHER
Northwestern University
OTHER
City of Hope Comprehensive Cancer Center
OTHER
University of Michigan Rogel Cancer Center
OTHER